Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
CytoDyn Announces Execution of Exclusive Agreement with American Regent for Distribution…
Commercial
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief…
Commercial
Abivax treats first patient in Phase 2b/3 ABX464 Covid-19 clinical trial
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
UK mulls joining EU coronavirus vaccines strategy – FirstWord Pharma
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
In one of biotech’s hottest areas and with big partners like…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Gilead’s Veklury gains conditional EU approval for treatment of COVID-19 –…
Clinical
The European Commission has Granted Orphan Medicinal Product Designation in the…
Clinical
Hydroxychloroquine found to significantly cut death rates in new COVID-19 study…
Clinical
Discovery of new step in how brain cells work could lead…
Home
Commercial
Lay off/Spin-off/Appointments
Lay off/Spin-off/Appointments
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lay off/Spin-off/Appointments
Cannabis Sativa, Inc. Reports Record First Quarter Revenues OTCBB:CBDS
Globenewswire News
-
July 2, 2020
Lay off/Spin-off/Appointments
Dr. David G. Kallend joins DalCor Pharmaceuticals as Chief Scientific Officer
Lay off/Spin-off/Appointments
AGTC Boosts AAV Manufacturing Productivity with Herpes Simplex Virus
Lay off/Spin-off/Appointments
Dr. David G. Kallend joins DalCor Pharmaceuticals as Chief Scientific Officer
Lay off/Spin-off/Appointments
Novavax Announces Updates to Leadership Team
Lay off/Spin-off/Appointments
Theravance Biopharma Appoints Deepika R. Pakianathan, Ph.D. to Board of Directors
Biospace News
-
July 2, 2020
0
Lay off/Spin-off/Appointments
Theravance Biopharma Appoints Deepika R. Pakianathan, Ph.D. to Board of Directors
Biospace News
-
July 2, 2020
0
Lay off/Spin-off/Appointments
Bolt Biotherapeutics Pushes Forward with Initiatives Following $93.5 Million Series C
Biospace News
-
July 1, 2020
0
Lay off/Spin-off/Appointments
ERYTECH Reports Voting Results from its Annual General Meeting Held on...
Globenewswire News
-
June 26, 2020
0
Lay off/Spin-off/Appointments
Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public...
Globenewswire News
-
June 26, 2020
0
1
2
3
...
47
Page 1 of 47
- Advertisement -
MOST POPULAR
Alnylam Submits CTA Application for ALN-AGT, an Investigational RNAi Therapeutic for...
March 11, 2019
GT Biopharma GTB-1550
June 13, 2019
Biogen Terminates Employee Who Fled to China After Testing Positive for...
March 20, 2020
Mesoblast Heart Failure Cell Therapy Receives Orphan Drug Designation From FDA...
June 24, 2019
Load more
HOT NEWS
Clinical
Lilly to Establish an Access Program for Patients as it Prepares...
Clinical
Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV To Treat...
Commercial
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
Phase III
XTANDI (enzalutamide) Demonstrates Significant Improvement in Overall Survival in Phase 3...
